Skip to main content
Clinical Trials/CTRI/2024/03/064337
CTRI/2024/03/064337
Not yet recruiting
Phase 3

Evaluation Of Clinical Periodontal Parameters And Pro-Resolvin Mediators Eicosapentanoic Acid (Epa) And Docosahexaenoic Acid (Dha) In Gingival Crevicular Fluid (Gcf) With Flax Seed Extract Gel As Local Drug Delivery In Treatment Of Stage 2 And Stage 3 Periodontitis Patients: A Randomised Controlled Trial - Not applicable

Jisha S Raj0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Jisha S Raj
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Jisha S Raj

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients diagnosed with Stage 2 and Stage 3 periodontitis in the age group of 25\-60 years with a minimum of a total of 24 natural teeth.
  • 2\. Sites having pocket probing depth (PPD) of \=5 mm and clinical attachment loss (CAL) of \=3mm in the maxillary teeth.

Exclusion Criteria

  • 1\. Patients suffering from any form of systemic diseases.
  • 2\. Patients currently on antibiotic/anti\-inflammatory therapy, steroids or hormonal therapy within the past 6 months.
  • 3\. Patients with history of any dental therapy in the past 14 days.
  • 4\. History of allergy in using any oral hygiene products.
  • 5\. Patients with oral abusive habits such as smoking , consumption of alcohol or tobacco or parafunctional habits (like bruxism and grinding of teeth)
  • 6\. Pregnant and lactating patients
  • 7\. Patients on a diet rich in omega fatty acids.

Outcomes

Primary Outcomes

Not specified

Similar Trials